top of page


  • Writer's picturePCPC

Developing the Next Generation PD-L1 Assays Using Precision Mass Spectrometry

The McGill node has received funding from the Genome Canada Genomic Applications Partnership Program (GAPP) to  develop PD-L1 Mass Spectrometry (MS)-based assays for use in immune-oncology.

View Full Article


Recent Posts

See All

CPTAC and researchers from the University of Victoria – Genome British Columbia Proteomics Centre just released over 130 quantitative, fit-for-purpose, multiplexed mouse multiple reaction monitoring (

In partnership with Agilent, we have upgraded 2 of our 6490 triple quadrupole mass spectrometers the the latest 6495b platforms. These newer instruments enable greater sensitivity and the ability to q

bottom of page